About Afon Technology
Afon Technology is a medical device business on a mission to develop Glucowear™, a completely non-invasive, continuous blood glucose monitor. Glucowear™ will empower Diabetics with the information they need to better manage their condition on a daily basis.
- Non-Invasive Glucose Monitoring
- Continuous Glucose Monitor
- Accurate Blood Glucose Readings
Afon Technology wins Innovation in STEM at Wales STEM Awards 2023
Non-invasive and real time blood glucose monitoring
The multi-skilled team at Afon Technology are working on a ground-breaking technology which will turn any smart watch into a glucose monitor.
The team have developed a sensor which will sit on the underside of the wrist, attached to the user’s watch strap.
Glucowear™ uses low power RF/microwave technology to track and record changes in blood glucose levels, in real time.
The sensor will feed back to a companion app on a smart device to communicate blood glucose readings immediately.
Our needle free technology will give accurate and real time results all day, every day, without the need for daily finger-pricking. Our device will remove a huge degree of pain as well as hassle from the lives of people with Diabetes.
Afon Technology are currently putting their sensor through rigorous testing and trials with a plan to start selling the device in 2024.
Interested in Investing in Afon Technology?
Why do we need the Afon device?
For years, people with Diabetes have had to do finger pricks to check their blood glucose levels. More recently, new devices have come to market which offer continuous glucose monitoring and are minimally invasive, but nonetheless still invasive.
Current Continuous Glucose Monitoring (CGM) devices have proven to be beneficial for control and self-management.
However, a lot of people with Diabetes can’t access or afford the current ‘best option’ on the market and therefore still need to perform 8 – 10 finger pricks per day.
What people with Diabetes really want and need is an affordable, non-invasive solution which offers real time blood glucose readings. No need to replace the device after a short time period, no risk of the device falling off or being caught by an item of clothing, discrete placement and one less thing that needs to be replaced or ordered every month!
It has been calculated that people with Diabetes have to make an extra 180 decisions every day concerning their Diabetes management! Our Glucowear™ removes a huge amount of stress from their decision making.
Find out about careers at AFON Technology
Our History
Afon Technology has come a long way since the concept of its life changing technology was discovered in 2005 by Dr Sabih Chaudhry (Founder & CEO).
Dr Chaudhry worked with the Royal Liverpool Hospital in 2013 to conduct the first trials on the technology and was also awarded the Bionow Award for Healthcare Project of the Year in 2014.
Since then, Dr Chaudhry has secured further private investment as well as being awarded grant funding and has built up a team of skilled and dedicated staff who have developed the technology for manufacture and are preparing for commercialisation.
The team at Afon Technology consists of world-renowned experts as well as people who are passionate about improving the lives of others.
Afon Technology have carried out several independent clinical trials with their Glucowear™ device which includes an ongoing NHS trial.
In December 2022, Afon Technology were awarded a €2.5m grant from the European Innovation Council. Afon were one of only six UK based winners to be awarded this prestigious prize funding from amongst thousands of applicants across Europe. This grant is designed to help individual start-ups and small companies to develop and scale up game changing innovations.
Dr Sabih Chaudhry BSC(HONS), PHD and CEO of Afon Technology appeared on Episode 21 of the Inpatient Podcast in February 2024.
The Inpatient Podcast has been bringing news and information to the Diabetes community since 2021. Discussing topics relating to Diabetes inpatient care, the podcast gives a platform to academics and healthcare practitioners to share their expertise to all.
If you host a podcast, news channel or other media and wish to talk with Dr Sabih Chaudhry, you can contact us here.
Sign up to receive email updates on our progress!
Winners of the Innovation in STEM Award 2023
Since the grant was awarded, Afon Technology have continued to develop their pioneering technology, releasing new images of the technology, and astounding the scientific community with their revolutionary Diabetes device.
In October 2023 Afon Technology were awarded a prestigious Wales STEM Award, the Innovation in STEM Award. Members of the Afon Technology team were able to attend the evening of awards and accept the highly respected accolade.
In a press release, Dr Sabih Chaudhry said: “I am incredibly proud of the entire Afon Technology team for receiving the Innovation in STEM Award.
“Our mission has always been to push the boundaries of what’s possible in healthcare technology, and winning this award is a testament to our dedication.
“This recognition motivates us to continue our journey, addressing diversity gaps, and inspiring the next generation to dream big and reach for the stars in the world of science and technology.”
2023 has also seen Afon Technology grow their team of scientists, clinical advisors, and administration staff as they come ever closer to their dream of revolutionising Diabetes care.
Frequently Asked Questions
Blood glucose monitoring is when a person tracks their blood glucose levels to identify information on when they go up and down.
A CGM is a small sensor device attached to the skin that measures how much glucose is in the interstitial fluid under your skin.
People with Diabetes need to measure their blood glucose continuously so they can take action if the levels go too high or too low.
Glucowear™ will be available online. We will release more specific information on where you will be able to purchase once the device is ready for market.
The cause of Type 1 Diabetes is unknown though it’s believed there is slightly higher risk if your parents or siblings have it.
For Type 2 Diabetes there are several risk factors. These include being overweight, smoking, being over 40, or over 25 if you’re Black African, African-Caribbean, Chinese, or South Asian.
Having high blood pressure and cholesterol, Polycystic Ovary Syndrome, heart disease, a sedentary lifestyle and some mental health conditions are also linked as risk factors for Type 2 Diabetes. For more information visit our page About Diabetes.
Long-term complications of Diabetes, also known as chronic complications, can include heart problems, nerve damage, foot problems, kidney disease, eye problems, gum disease, sexual problems, and an increased risk of cancer and strokes. For more information visit our page About Diabetes.
The main treatment for Diabetes is insulin which can come in the form of an injection or insulin pump. A healthy diet and exercise can help treat Diabetes, especially Type 2. Emotional support is an important part of Diabetes management. For more information visit our page About Diabetes.
Type 1 Diabetes is when the body can’t make the insulin hormone, which is different to Type 2 Diabetes. Type 2 Diabetes is when the body doesn’t react to insulin, or the pancreas doesn’t make enough.
